STAGE 1 INDUSTRIAL RESEARCH
STAGE 2 DEVELOPMENT WORKS
STAGE 3 DEVELOPMENT WORKS
Manufacturing tests of the innovative versatile Crosimax alloy in three variants being a reflection of the patterns developed by the Subcontractor at Stage 1.
Production of a reference batch of the new alloy.
STAGE 4 PRE-IMPLEMENTATION WORKS
Patent application covering the method of the Crosimax alloy manufacturing in terms of enriching the feedstock mixture at the furnace phase.
Preparation of documentation concerning a new manufacturing technology.
An innovative versatile reducing agent of chromium trioxide – Crosimax – will be the project’s result. The alloy, having substantially higher reducing potential than FeSiCr grades used so far while maintaining low carbon content and other adverse substances, will be designed to be used in the manufacturing process of ultra-low carbon ferrochromium (ULC FeCr) and in the process of deoxidising of high-chromium ferritic and austenitic stainless steel which is widely used in the mechanical engineering or food industry, and above all, it is a main material for manufacturing of medical devices, from needles and vessels to surgical tools and parts of prosthetic devices. Now, on the market there are FeSiCr alloys with the content of Si reaching the level of max. 50%, with the Cr content min. 28%, C content max. 0.1%, P content max. 0.03%, and S max. 0.02%
The project is co-financed with the funds of the European Fund for Regional Development within the Submeasure 1.1.1 “Industrial research and development works implemented by enterprises” within the Smart Growth Operational Programme 2014-2020.